
Shares of Johnson Controls International JCI.N up 2.6% premarket to $89.94 after UBS upgrades to 'buy' from 'neutral', highlighting its new leadership
Shares of building solutions co could open at fresh record high, if gains hold
UBS boosts PT by $13 to $103, implying 17.5% upside to stock's last close
Brokerage said it's positive on CEO appointment of Joakim Weidemanis, pointing out that as head of Danaher's DHR.N diagnostics business he oversaw 600 basis points of operating margin improvement during 2020-2024
Overlaying this with JCI's margin opportunity, UBS said it has "greater confidence" in profit improvement potential, adding EPS could reach $6 in FY28 (+6% above consensus and +20% CAGR)
Last Weds, JCI shares jumped 11% to close at $86.01 after Ireland-based firm named Weidemanis CEO, as part of succession plan announced last year following talks with activist investor Elliott Investment, and lifted its 2025 adj profit forecast
Of 23 analysts covering JCI, recommendation breakdown is 13 "strong buy" or "buy", rest "hold"; median PT of $95.50 up from $88 a month ago, per LSEG data
Through Fri, shares up 11% YTD vs 4% gain in S&P 500 Industrials .SPLRCI and 2.5% advance in S&P 500 .SPX. Stock was trading around $55.50 a year ago